Advertisement

Loading...

Medios AG

MEDOFPNK
Healthcare
Medical - Distribution
$50.00
$0.00(0.00%)
U.S. Market opens in 13h 29m

Medios AG Fundamental Analysis

Medios AG (MEDOF) shows weak financial fundamentals with a PE ratio of 50.04, profit margin of 1.09%, and ROE of 4.26%. The company generates $1.9B in annual revenue with moderate year-over-year growth of 5.51%.

Key Strengths

Current Ratio1.74

Areas of Concern

ROE4.26%
Operating Margin2.21%
PEG Ratio3.62
We analyze MEDOF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 44.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
44.7/100

We analyze MEDOF's fundamental strength across five key dimensions:

Efficiency Score

Weak

MEDOF struggles to generate sufficient returns from assets.

ROA > 10%
2.34%

Valuation Score

Weak

MEDOF trades at a premium to fair value.

PE < 25
50.04
PEG Ratio < 2
3.62

Growth Score

Moderate

MEDOF shows steady but slowing expansion.

Revenue Growth > 5%
5.51%
EPS Growth > 10%
-35.44%

Financial Health Score

Excellent

MEDOF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.74

Profitability Score

Weak

MEDOF struggles to sustain strong margins.

ROE > 15%
4.26%
Net Margin ≥ 15%
1.09%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is MEDOF Expensive or Cheap?

P/E Ratio

MEDOF trades at 50.04 times earnings. This suggests a premium valuation.

50.04

PEG Ratio

When adjusting for growth, MEDOF's PEG of 3.62 indicates potential overvaluation.

3.62

Price to Book

The market values Medios AG at 2.13 times its book value. This may indicate undervaluation.

2.13

EV/EBITDA

Enterprise value stands at 13.78 times EBITDA. This signals the market has high growth expectations.

13.78

How Well Does MEDOF Make Money?

Net Profit Margin

For every $100 in sales, Medios AG keeps $1.09 as profit after all expenses.

1.09%

Operating Margin

Core operations generate 2.21 in profit for every $100 in revenue, before interest and taxes.

2.21%

ROE

Management delivers $4.26 in profit for every $100 of shareholder equity.

4.26%

ROA

Medios AG generates $2.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.34%

Following the Money - Real Cash Generation

Operating Cash Flow

Medios AG generates limited operating cash flow of $94.77M, signaling weaker underlying cash strength.

$94.77M

Free Cash Flow

Medios AG produces free cash flow of $87.60M, offering steady but limited capital for shareholder returns and expansion.

$87.60M

FCF Per Share

Each share generates $3.57 in free cash annually.

$3.57

FCF Yield

MEDOF converts 8.63% of its market value into free cash.

8.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

50.04

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

3.62

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.13

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.53

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.04

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How MEDOF Stacks Against Its Sector Peers

MetricMEDOF ValueSector AveragePerformance
P/E Ratio50.0428.31 Worse (Expensive)
ROE4.26%699.00% Weak
Net Margin1.09%-131318.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio1.742775.16 Neutral
ROA2.34%-14513.00% (disorted) Weak

MEDOF outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Medios AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

117.20%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-23.36%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

9873.70%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ